Yang K D, Chao C Y, Shaio M F
Chang Gung Children's Hospital at Kaohsiung, Taiwan.
Acta Haematol. 1998;99(4):191-9. doi: 10.1159/000040838.
All-trans retinoic acid (tRA) has been shown to promote terminal differentiation of promyelocytic leukemia cells, but frequently induce hyperleukocytosis and pulmonary leakage syndrome. Employing pentoxifylline (PTX), a phosphodiesterase inhibitor which could raise intracellular cAMP and modulate leukocyte activation, we sought to investigate if PTX could enhance tRA-induced promyelocytic leukemic cell differentiation but suppress tRA-augmented growth and activation of human granulocytes. tRA could significantly suppress clonal growth of U937 and HL-60 leukemic cells but enhanced the CFU-GM formation of normal bone marrow cells (22 +/- 6 vs. 90 +/- 16 CFU/well). PTX significantly augmented tRA suppression of clonal growth of U937 and HL-60 leukemic cells but suppressed tRA-augmented CFU-GM formation of normal bone marrow cells (90 +/- 16 vs. 25 +/- 9 CFU/well). In addition, PTX enhanced tRA-induced growth inhibition and differentiation of promyelocytic HL-60 leukemic cells, but suppressed respiratory burst activation by the immature granulocytic HL-60 cells and suppressed CD11b adhesion molecule expression by mature granulocytes. PTX similar to dibutyric cAMP promoted HL-60 myelocytic leukemic cell differentiation and growth inhibition, whereas PTX, in contrast to dibutyric cAMP which could augment phorbol myristate acetate (PMA)-elicited respiratory burst activity by immature granulocytes, suppressed the PMA-elicited respiratory burst activity by immature and mature granulocytes. PTX did not raise the intracellular cAMP level of HL-60 cells, but partly suppressed the dibutyric cAMP-elicited elevation of intracellular cAMP level. Results from these studies suggest that PTX might act through different signaling pathways to enhance tRA-induced myelocytic leukemic cell differentiation but prevent from hyperreactive normal granulopoiesis and granulocyte activation.
全反式维甲酸(tRA)已被证明可促进早幼粒细胞白血病细胞的终末分化,但常诱导白细胞增多症和肺渗漏综合征。使用己酮可可碱(PTX),一种可提高细胞内cAMP并调节白细胞活化的磷酸二酯酶抑制剂,我们试图研究PTX是否能增强tRA诱导的早幼粒细胞白血病细胞分化,但抑制tRA增强的人粒细胞生长和活化。tRA可显著抑制U937和HL-60白血病细胞的克隆生长,但增强正常骨髓细胞的CFU-GM形成(22±6对90±16 CFU/孔)。PTX显著增强tRA对U937和HL-60白血病细胞克隆生长的抑制作用,但抑制tRA增强的正常骨髓细胞CFU-GM形成(90±16对25±9 CFU/孔)。此外,PTX增强tRA诱导的早幼粒细胞HL-60白血病细胞的生长抑制和分化,但抑制未成熟粒细胞HL-60细胞的呼吸爆发活化,并抑制成熟粒细胞的CD11b粘附分子表达。与二丁酰cAMP相似,PTX促进HL-60髓细胞白血病细胞分化和生长抑制,而与二丁酰cAMP相反,二丁酰cAMP可增强未成熟粒细胞佛波酯肉豆蔻酸酯(PMA)引发的呼吸爆发活性,PTX抑制未成熟和成熟粒细胞PMA引发的呼吸爆发活性。PTX未提高HL-60细胞的细胞内cAMP水平,但部分抑制二丁酰cAMP引发的细胞内cAMP水平升高。这些研究结果表明,PTX可能通过不同的信号通路发挥作用,以增强tRA诱导的髓细胞白血病细胞分化,但防止正常粒细胞生成和粒细胞活化过度反应。